Thus, diminishing the production of IL-1β or TNF-α in macrophages by inhibiting the M1 polarization and/or NLRP3 inflammasome activation via the NF-κB signal pathway could be an effective strategy to treat gouty arthritis. Here, NLRP3 is linked to gout.